Verona Pharma Plc Profit Margin

Verona Pharma Plc posts a profit margin of -36.62% as of June 2025. That compares with -133.56% in the prior-year period — up 99.7% year over year. That is below the Healthcare sector average of 15.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Verona Pharma Plc's profit margin was -133.56%. The latest reading is -36.62% — a 99.7% year-over-year increase (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.58% is typical. Verona Pharma Plc's -36.62% is lower that level. That is roughly 335.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Verona Pharma Plc's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -36.62% as of June 2025; use YoY and peer views to separate noise from signal.

Context for VRNA's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.58%), and (3) consistency with growth and profitability. This page covers the first two; Verona Pharma Plc's other metric pages and overview cover the third.